Challenges to interpreting patient reported outcomes in clinical trials: author rejoinder

It is a pleasure to respond to the editorial by Professor Diane L. Fairclough, who has made foundational contributions to the design and analysis of clinical trials that use patient reported outcomes (PROs) (1). I thank her for adding to the discussion of PRO interpretation, and largely agree with the points raised.